Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 10, 2010, Pages 614-616

  Ramos, J M ^a   Garcia Sepulcre M F ^a   Masia M ^a   Brotons, A ^a   Grau, M C ^a   Gutierrez F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Crohn's diseases; Infliximab; Listeria

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZATHIOPRINE; BACTERIAL DNA; ETANERCEPT; GENTAMICIN; INFLIXIMAB; MESALAZINE; PREDNISONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; CENTRAL NERVOUS SYSTEM INFECTION; CROHN DISEASE; DNA DETERMINATION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG USE; ENTERITIS; HOST RESISTANCE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; LETTER; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE MIGRATION; MALAISE; NONHUMAN; WEAKNESS; CASE REPORT; DRUG ANTAGONISM; FEMALE; MIDDLE AGED;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LISTERIOSIS; MESALAMINE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952197426     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010001000014     Document Type: Letter

References (11)

1. Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 2003; 48: 319-324.
2. Morelli J, Wilson FA. Does administration of infliximab increase susceptibility to listeriosis? Am J Gastroenterol 2000; 95: 841-842.
3. Kamath BM, Mamula P, Baldassano RN, Markowitz JE. Listeria meningitis after treatment with infliximab. J Pediatr Gastroenterol Nutr 2002; 34: 410-412.
4. Joosten AA, van Olffen GH, Hageman G Meningitis due to Listeria monocytogenes as a complication of infliximab therapy. Ned Tijdschr Geneeskd 2003; 147: 1470-1472.
5. Tweezer-Zaks N, Shiloach E, Spivak A, Rapoport M, Novis B, Langevitz P. Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha. Isr Med Assoc J 2003; 5: 829-830.
6. de la Fuente Penco B, Marcó Piella A, Riera Mestre A, Boadas Mir J. Sepsis caused by Listeria monocytogenes related with the use of infliximab. Med Clin (Barc) 2005; 124: 398.
7. Williams G, Khan AA, Schweiger F. Listeria meningitis complicating infliximab treatment for Crohn's disease. Can J Infect Dis Med Microbiol 2005; 16: 289-292.
8. Dederichs F, Pinciu F, Gerhard H, Eveld K, Stallmach A. Listeria meningitis in a patient with Crohn's disease--a seldom, but clinically relevant adverse event of therapy with infliximab. Z Gastroenterol 2006;44:657-660.
9. Osuna Molina R, Ferrer Ríos T, Gallego Gallegos R, Ramos Lora M, Ynfante Ferrús M, Figueruela López B. Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease. RevEspEnfermDig 2006;98:60-61.
10. Ramanampamonjy RM, Laharie D, Bonnefoy B, Vergniol J, Amouretti M. Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis. Gastroenterol Clin Biol 2006; 30: 157-158.
11. Izbéki F, Nagy F, Szepes Z, Kiss I, Lonovics J, Molnár T. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease. Inflamm Bowel Dis 2008; 14: 429-431.